US 9456997
Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure
granted A61KA61K31/137A61K31/138
Quick answer
US patent 9456997 (Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/137, A61K31/138, A61K31/165, A61K31/35